Markets:

Overview

News

Currencies

International

Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

92.77 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

59 60 Next >

Biotech Bull Market Is Intact But SMIDs Are Too Volatile ↗

July 22, 2024

It was another wild week for the market as it had to contend with a lot of news.

Via Talk Markets

Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst ↗

July 22, 2024

Ionis Pharmaceuticals releases positive results from Phase 1/2 study of ION582 for Angelman syndrome, showing consistent clinical improvements in communication, cognition, and motor function. Safety...

Via Benzinga

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? ↗

July 22, 2024

The big pharma company's top drug is losing ground, but its dividend keeps rising.

Via The Motley Fool

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' ↗

July 18, 2024

Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.

Via Benzinga

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗

July 21, 2024

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Via Benzinga

European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment ↗

July 17, 2024

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed.

Via Benzinga

The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024 ↗

July 15, 2024

Undervalued Nasdaq 100 stocks may not be as rare as hen's teeth but not quite so plentiful amid a raging bull market.

Via InvestorPlace

7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns ↗

July 10, 2024

These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.

Via InvestorPlace

United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win ↗

July 05, 2024

New leadership in the United Kingdom could make several sectors standout going forward. Here's what experts are saying after the election.

Via Benzinga

Topics ETFs

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients ↗

July 05, 2024

A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.

Via Investor's Business Daily

3 Set-It-and-Forget-It Stocks for Lasting Financial Security ↗

July 02, 2024

Three set-it-and-forget-it stocks powered by consistent growth and sustainable profitability to buy for wealth compounding.

Via InvestorPlace

AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment ↗

July 01, 2024

The European Medicines Agency has accepted AstraZeneca's marketing authorization application for sipavibart, an investigational long-acting antibody for pre-exposure prophylaxis of COVID-19 in...

Via Benzinga

7 Biotech Stocks to Boost Your Portfolio to Peak Health ↗

June 26, 2024

With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.

Via InvestorPlace

China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients ↗

June 26, 2024

China has approved AstraZeneca's Tagrisso (osimertinib) combined with pemetrexed and platinum-based chemotherapy for first-line treatment of locally advanced or metastatic EGFR-mutated non-small cell...

Via Benzinga

AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung Cancer, But Hits Primary Goal In Phase 3 Bladder Cancer Study ↗

June 25, 2024

AstraZeneca's ADJUVANT BR.31 Phase 3 trial reveals Imfinzi didn't meet the primary endpoint for disease-free survival in early-stage NSCLC. Despite this, Imfinzi's safety profile remains consistent.

Via Benzinga

3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains ↗

June 24, 2024

These are the undervalued pharma stocks and represent companies with a deep research pipeline, that provides sustained growth visibility.

Via InvestorPlace

Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case ↗

June 24, 2024

The U.S. Supreme Court supports pharmaceutical companies, led by AstraZeneca, in a lawsuit accusing them of funding terrorism in Iraq, dismissing a lower court's ruling and sending the case back for...

Via Benzinga

Topics Lawsuit

Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success ↗

June 24, 2024

The challenge for Alnylam now will be to find and diagnose patients with the condition known as ATTR-CM, which is considered rare.

Via InvestorPlace

The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits ↗

June 23, 2024

Explore three top growth-ready healthcare stocks to buy amid rising demand for healthcare services globally.

Via InvestorPlace

3 No-Brainer Stocks to Buy for Under $100 Right Now ↗

June 22, 2024

You won't need much money to start investing in these great stocks.

Via The Motley Fool

Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments ↗

June 21, 2024

Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.

Via Benzinga

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment ↗

June 18, 2024

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...

Via Benzinga

AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial ↗

June 18, 2024

AstraZeneca announced that the CAPItello-290 Phase 3 trial for Truqap (capivasertib) combined with paclitaxel in advanced or metastatic triple-negative breast cancer did not meet primary endpoints for...

Via Benzinga

What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? ↗

June 17, 2024

Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for...

Via Benzinga

FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer ↗

June 17, 2024

AstraZeneca's breakthrough drug, Imfinzi, combined with chemotherapy, has been officially approved by the FDA to treat advanced forms of endometrial cancer with mismatch repair deficiency. This...

Via Benzinga

3 Best Stocks to Buy From the Fantastic 5 ↗

June 17, 2024

Although the best Fantastic 5 stocks offer much relevance and plenty of upside potential, they’re still underappreciated.

Via InvestorPlace

AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression In Patients With Certain Type Of Blood Cancer ↗

June 17, 2024

AstraZeneca shares data from the ECHO Phase 3 trial on Calquence plus bendamustine and rituximab in untreated mantle cell lymphoma patients over 65.

Via Benzinga

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks ↗

June 13, 2024

The companies are closing in on the finish line for two new COPD treatments.

Via Investor's Business Daily

Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club ↗

June 12, 2024

Enthusiasm is growing for a looming approval in COPD treatment.

Via Investor's Business Daily

3 Crazy Good Stocks to Buy With $500 Right Now ↗

June 12, 2024

For investors with only a little money to spare, these three supercharged stocks represent an outrageous opportunity for future growth.

Via InvestorPlace

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

Headline News about AstraZeneca PLC - American Depositary Shares

Starting at $3.75/week.

Subscribe Today